|

PF-07275315-dose 3 Clinical Trials

1 actively recruiting trial across 1 location

No change since June 2026

Pipeline

Phase 2/3: 1

Top Sponsors

  • Pfizer1

Indications

  • Moderate to Severe Chronic Obstructive Pulmonary Disease1
  • COPD1

Birmingham, Alabama1 trial

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

University of Alabama at Birmingham Lung Health Center

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.